#molecular diagnostic market

Discover 2 curated intelligence briefings related to this specific topic.

Latin America Just Broke the Biopharma Monopoly

The region is moving beyond simple vaccine filling to full-scale biomanufacturing, driven by a desperate need for health sovereignty and an untapped biological goldmine.

Read Analysis

Science & Health

Can We Afford the Future of Medicine?

While the oncology molecular diagnostic market races toward an 8.5 billion dollar valuation, a June 2026 wave of insurance tax hikes and trillion-dollar credit card debts are making the cost of survival a luxury.

Read Analysis